StonvexLoading…
StonvexStonvexStonvexCore line items from NTRP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-02-28 | Annual 2024 2024-02-29 | Annual 2023 2023-02-28 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $501.42K | $458.75K | $382.83K | $630.43K |
Operating Income | $-7.41M | $-5.68M | $-4.95M | $-8.75M |
Net Income | $-10.12M | $-7.33M | $-5.03M | $-8.69M |
EPS (Diluted) | $-2.23 | $-32.12 | $-70.32 | $-0.83 |
Total Assets | $9.94M | $5.09M | $5.88M | $5.70M |
Total Liabilities | $2.57M | $1.96M | $5.40M | $629.20K |
Cash & Equivalents | $1.06M | $323.81K | $282.48K | $2.85M |
Free Cash Flow OCF − CapEx | Not available | $-5.74M | $-3.80M | $-8.38M |
Shares Outstanding | 1.66M | 936.43K | 83.37K | 10.50M |